In an interview for NBC News, Vin Gupta, MD, MPA, MSc, affiliate assistant professor of Health Metrics Sciences at the Institute for Health Metrics and Evaluation (IHME) at…
Dileep R. Yavagal, MD, Professor of Neurology & Neurosurgery and Chief Interventional Neurologist at the University of Miami – Miller School of Medicine, describes a treatment that has…
Kevin Hauser, Director New Business Development at MedeFile International discusses the advanced features and benefits of their technology. These include MedeMinder and the Interactive Healthcare Calendar, which function…
Kevin Hauser, Director of New Business Development at MedeFile International discusses their technology. MedeFile has developed a proprietary system for gathering and digitizing medical records so that individuals…
NEW YORK (Reuters Health) – The nucleoside reverse transcriptase inhibitors (NRTIs) abacavir and didanosine, and the protease inhibitors (PIs) indinavir and lopinavir-ritonavir, all increase the risk of myocardial…
NEW YORK (Reuters Health) – For patients presenting to the emergency department (ED) with migraine, IV prochlorperazine with diphenhydramine is more effective than subcutaneous sumatriptan, a small prospective…
NEW YORK (Reuters Health) – All cesarean sections put women at increased risk of adverse events, including death, according to the World Health Organization’s Global Survey on Maternal…
NEW YORK (Reuters Health) – Just like cocaine and other drugs that increase brain dopamine levels, the dopamine agonists used to treat Parkinson disease can also produce a…
NEW YORK (Reuters Health) – Patients with non-ST-segment elevation acute coronary syndrome and elevated troponin T get no long term benefits from early invasive treatment as opposed to…
NEW YORK (Reuters Health) – Ventilator-associated pneumonia is less likely to be fatal when patients are intubated with a silver-coated endotracheal tube, according to a post hoc analysis…
NEW YORK (Reuters Health) – Magnetic guidewire navigation is feasible in primary percutaneous coronary intervention (PCI), according to results of a noninferiority trial performed in the Netherlands. Moreover,…
NEW YORK (Reuters Health) – When oxytocin is unavailable, misoprostol appears to be a viable alternative for first-line treatment of primary postpartum hemorrhage, according to two articles published…
